The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...
3h
Zacks Investment Research on MSNThis Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your RadarWhether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the right ...
Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth: Also, EPS is estimated to ramp higher ...
5d
Zacks Investment Research on MSNHere's Why You Should Add Veeva Systems Stock to Your Portfolio NowVeeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...
Veeva Systems (NYSE: VEEV) today announced Veeva CRM Pulse, a data subscription that provides quarterly healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results